Systemic anti-commensal response to fungi analyzed by flow cytometry is related to gut mycobiome ecology.

Flow cytometry Humoral immunity ITS rRNA gene sequencing Immunoglobulin G Mycobiota Systemic anti-commensal responses

Journal

Microbiome
ISSN: 2049-2618
Titre abrégé: Microbiome
Pays: England
ID NLM: 101615147

Informations de publication

Date de publication:
15 11 2020
Historique:
received: 06 07 2020
accepted: 15 09 2020
entrez: 16 11 2020
pubmed: 17 11 2020
medline: 2 4 2021
Statut: epublish

Résumé

Interest for the study of gut mycobiota in relation with human health and immune homeostasis has increased in the last years. From this perspective, new tools to study the immune/fungal interface are warranted. Systemic humoral immune responses could reflect the dynamic relationships between gut mycobiota and immunity. Using a novel flow cytometry technology (Fungi-Flow) to determine immunoglobulin (Ig) responses to fungi, we studied the relationships between gut mycobiota and systemic humoral anti-commensal immunity. The Fungi-Flow method allows a sensitive and specific measurement of systemic IgG responses against 17 commensal and environmental fungi from the two main divisions; Ascomycota and Basidiomycota. IgG responses exhibited a high inter-individual variability. Anti-commensal IgG responses were contrasted with the relative abundance, alpha-diversity, and intra-genus richness of fungal species in gut mycobiota of twenty healthy donors. Categorization of gut mycobiota composition revealed two differentiated fungal ecosystems. Significant difference of anti-Saccharomyces systemic IgG responses were observed in healthy donors stratified according to the fungal ecosystem colonizing their gut. A positive and significant correlation was observed between the variety of IgG responses against fungal commensals and intestinal alpha-diversity. At the level of intra-genus species richness, intense IgG responses were associated with a low intra-genus richness for known pathobionts, but not commensals. Fungi-Flow allows an easy and reliable measure of personalized humoral responses against commensal fungi. Combining sequencing technology with our novel Fungi-Flow immunological method, we propose that there are at least two defined ecosystems in the human gut mycobiome associated with systemic humoral responses. Fungi-Flow opens new opportunities to improve our knowledge about the impact of mycobiota in humoral anti-commensal immunity and homeostasis. Video Abstract.

Sections du résumé

BACKGROUND
Interest for the study of gut mycobiota in relation with human health and immune homeostasis has increased in the last years. From this perspective, new tools to study the immune/fungal interface are warranted. Systemic humoral immune responses could reflect the dynamic relationships between gut mycobiota and immunity. Using a novel flow cytometry technology (Fungi-Flow) to determine immunoglobulin (Ig) responses to fungi, we studied the relationships between gut mycobiota and systemic humoral anti-commensal immunity.
RESULTS
The Fungi-Flow method allows a sensitive and specific measurement of systemic IgG responses against 17 commensal and environmental fungi from the two main divisions; Ascomycota and Basidiomycota. IgG responses exhibited a high inter-individual variability. Anti-commensal IgG responses were contrasted with the relative abundance, alpha-diversity, and intra-genus richness of fungal species in gut mycobiota of twenty healthy donors. Categorization of gut mycobiota composition revealed two differentiated fungal ecosystems. Significant difference of anti-Saccharomyces systemic IgG responses were observed in healthy donors stratified according to the fungal ecosystem colonizing their gut. A positive and significant correlation was observed between the variety of IgG responses against fungal commensals and intestinal alpha-diversity. At the level of intra-genus species richness, intense IgG responses were associated with a low intra-genus richness for known pathobionts, but not commensals.
CONCLUSIONS
Fungi-Flow allows an easy and reliable measure of personalized humoral responses against commensal fungi. Combining sequencing technology with our novel Fungi-Flow immunological method, we propose that there are at least two defined ecosystems in the human gut mycobiome associated with systemic humoral responses. Fungi-Flow opens new opportunities to improve our knowledge about the impact of mycobiota in humoral anti-commensal immunity and homeostasis. Video Abstract.

Identifiants

pubmed: 33190643
doi: 10.1186/s40168-020-00924-8
pii: 10.1186/s40168-020-00924-8
pmc: PMC7667786
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

159

Références

Gut. 2017 Jun;66(6):1039-1048
pubmed: 26843508
Mucosal Immunol. 2020 Jan;13(1):3-11
pubmed: 31413347
Cell Host Microbe. 2012 May 17;11(5):447-56
pubmed: 22607798
Hepatology. 2020 Feb;71(2):522-538
pubmed: 31228214
Nat Rev Dis Primers. 2018 May 11;4:18026
pubmed: 29749387
Appl Environ Microbiol. 2007 Aug;73(16):5261-7
pubmed: 17586664
Front Microbiol. 2019 Mar 21;10:438
pubmed: 30949136
Clin Rev Allergy Immunol. 2013 Oct;45(2):152-61
pubmed: 23292495
Front Immunol. 2017 Nov 22;8:1614
pubmed: 29213272
Microbiome. 2017 Nov 25;5(1):153
pubmed: 29178920
Front Microbiol. 2015 Feb 13;6:89
pubmed: 25762987
Diagn Microbiol Infect Dis. 2011 Aug;70(4):492-8
pubmed: 20846815
Cell Host Microbe. 2012 Aug 16;12(2):223-32
pubmed: 22901542
Gut. 2011 Nov;60(11):1506-19
pubmed: 21515549
Cell Host Microbe. 2017 Aug 9;22(2):156-165
pubmed: 28799901
J Allergy Clin Immunol. 2019 Apr;143(4):1575-1585.e4
pubmed: 30554723
Curr Fungal Infect Rep. 2018;12(3):127-136
pubmed: 30294405
FEMS Microbiol Rev. 2017 Jul 1;41(4):479-511
pubmed: 28430946
Nat Rev Microbiol. 2016 Mar;14(3):163-76
pubmed: 26853116
Front Microbiol. 2017 Jul 31;8:1432
pubmed: 28824566
Cell Host Microbe. 2019 Mar 13;25(3):432-443.e6
pubmed: 30870623
Immunol Lett. 2015 Nov;168(1):64-72
pubmed: 26386376
Annu Rev Pathol. 2017 Jan 24;12:359-385
pubmed: 28068483
J Crohns Colitis. 2016 Mar;10(3):296-305
pubmed: 26574491
Nat Rev Gastroenterol Hepatol. 2015 Feb;12(2):77-87
pubmed: 25385227
Cell Host Microbe. 2018 Dec 12;24(6):847-856.e4
pubmed: 30503509
PLoS Pathog. 2014 Apr 10;10(4):e1004050
pubmed: 24722226
J Proteome Res. 2017 Jan 6;16(1):335-345
pubmed: 27539120
Clin Microbiol Infect. 2019 Jul;25(7):892-897
pubmed: 30394360
Microb Ecol. 2018 May;75(4):821-829
pubmed: 29110065
Front Microbiol. 2019 Jan 09;9:3249
pubmed: 30687254
Science. 2018 Jan 12;359(6372):232-236
pubmed: 29326275
Nat Protoc. 2016 Aug;11(8):1531-53
pubmed: 27466712
Virulence. 2017 Apr 3;8(3):352-358
pubmed: 27736307
Nat Rev Immunol. 2017 Oct;17(10):635-646
pubmed: 28604735
Carbohydr Res. 1996 Jan 11;280(2):303-13
pubmed: 8593641
Front Immunol. 2019 Sep 13;10:2189
pubmed: 31572394
Gastroenterology. 2006 May;130(6):1764-75
pubmed: 16697740
Fungal Genet Biol. 2019 Jun;127:45-49
pubmed: 30849443
BMC Microbiol. 2012 Nov 08;12:255
pubmed: 23136846
Curr Drug Targets Cardiovasc Haematol Disord. 2003 Sep;3(3):209-17
pubmed: 12871039
Nat Rev Microbiol. 2011 Dec 12;10(2):112-22
pubmed: 22158429
Eur Respir Rev. 2018 May 15;27(148):
pubmed: 29769295
Nat Rev Microbiol. 2011 Aug 16;9(10):737-48
pubmed: 21844880
Clin Microbiol Infect. 2016 Aug;22(8):660-1
pubmed: 27475740
PLoS One. 2014 Sep 11;9(9):e106994
pubmed: 25210972
Nat Med. 2016 Oct;22(10):1187-1191
pubmed: 27618652
BMC Microbiol. 2012 Apr 17;12:56
pubmed: 22510143
Immunity. 2019 Jun 18;50(6):1365-1379
pubmed: 31216461
Semin Immunopathol. 2015 Mar;37(2):187-97
pubmed: 25404121
Arch Biochem Biophys. 1996 Dec 1;336(1):49-58
pubmed: 8951034

Auteurs

Alicia Moreno-Sabater (A)

Sorbonne Université, Inserm U1135, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France. alicia.moreno-sabater@sorbonne-universite.fr.
Service de Parasitologie-Mycologie AP-HP, Hôpital Saint-Antoine, 75012, Paris, France. alicia.moreno-sabater@sorbonne-universite.fr.

Gaelle Autaa (G)

Sorbonne Université, Inserm U1135, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.

Delphine Sterlin (D)

Sorbonne Université, Inserm U1135, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.
Service d'immunologie, AP-HP, Hôpital Pitié-Salpêtrière, 75013, Paris, France.
Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 Inserm, 75015, Paris, France.

Amenie Jerbi (A)

Service d'immunologie, AP-HP, Hôpital Pitié-Salpêtrière, 75013, Paris, France.

Remy Villette (R)

Sorbonne Université, Inserm U1135, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.

Johanna B Holm (JB)

Institute for Genome Sciences and Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.

Christophe Parizot (C)

Service d'immunologie, AP-HP, Hôpital Pitié-Salpêtrière, 75013, Paris, France.

Sameh Selim (S)

College of Agricultural Sciences AGHYLE Res, Unit. Institut Polytechnique UniLaSalle, 60026, Beauvais, France.

Yaye Senghor (Y)

Service de Parasitologie-Mycologie AP-HP, Hôpital Saint-Antoine, 75012, Paris, France.

Pascale Ghillani-Dalbin (P)

Service d'immunologie, AP-HP, Hôpital Pitié-Salpêtrière, 75013, Paris, France.

Claude Bachmeyer (C)

AP-HP, Hôpital Tenon 4, rue de la Chine, 75020, Paris, France.

Christophe Hennequin (C)

Service de Parasitologie-Mycologie AP-HP, Hôpital Saint-Antoine, 75012, Paris, France.
Centre de Recherche Saint-Antoine, CRSA, AP-HP, Sorbonne Université, Inserm, 75012, Paris, France.

Guy Gorochov (G)

Sorbonne Université, Inserm U1135, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.
Service d'immunologie, AP-HP, Hôpital Pitié-Salpêtrière, 75013, Paris, France.

Martin Larsen (M)

Sorbonne Université, Inserm U1135, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), 75013, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH